The occurrence of apoptosis in myocardium has been identified in failing human hearts as well as in experimental models subsequent to myocardial infarction [27] [28] [29] . Heart failure due to pressure overload [1, 30] 
Introduction

It is now becoming evident that programmed cell death (apoptosis) is one of the important determinants of cardiac contractile dysfunction under different pathological conditions
. Several investigators [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Furthermore, the activation of some proteins such as p38 MAPK and NFB as well as deactivation of Erk1/2, BAD and Bcl-2 due to phosphorylation/dephosphorylation process determine the extent of activation of mitochondrial caspases for the occurrence of apoptosis [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . Thus, in spite of the complexities of signal transduction mechanisms involved in the genesis of cardiomyocyte apoptosis, the process of cellular death appears to represent an important feature for remodelling (changes in the size and shape) of the myocardium and cardiac dysfunction [24] [25] [26] .
have shown that different factors such as intracellular Ca 2ϩ -overload, oxidative stress and cytokines including tumour necrosis factor-alpha (TNF-␣) play a critical role in the development of cardiomyocyte apoptosis. In particular, the upregulation or down-regulation of some proteins such as protein kinase C (PKC) isozymes, caspases 3 and 9, p38 mitogen activated protein kinase (p38 MAPK), nuclear factor (NFB), extracellular protein kinases (Erk1/2), BAD, and Bcl-2 are considered to be intimately involved in the genesis of cell death or cell survival
The occurrence of apoptosis in myocardium has been identified in failing human hearts as well as in experimental models subsequent to myocardial infarction [27] [28] [29] . Heart failure due to pressure overload [1, 30] or volume overload [31] [32, 33] . Likewise, contractile dysfunction due to drug-induced cardiomyopathy has been associated with the presence of apoptosis in the heart [34, 35] . Furthermore, cardiomyocyte apoptosis has been observed in heart failure in dilated cardiomyopathy due to oxidative stress in dogs [36] . Although the J2N-k strain of hamsters has been shown to form an excellent model of dilated cardiomyopathy [37] [38] [39] [40] 
Materials and methods
All experimental protocols used in this study
Echocardiographic assessment
This method is the same as described previously [41] . 
Statistical analysis
Results
Cardiac performance of cardiomyopathic hamsters
The data for general characteristics and echocardiographic assessment of control (J2N-n strain) and cardiomyopathic (J2N-k strain) are shown in Fig. 1 and Table 1 . Figure 1 shows the MMode echocardiographic images of control (Fig. 1A) and cardiomyopathic (Fig. 1B) hamster hearts. Significant depressions in EF (Fig. 1C) , FS (Fig. 1D) , CO (Fig. 1E) and HR (Fig. 1F) 
Protein content of various effectors in cardiomyopathic hearts
Western blot analysis revealed an increased protein content of PKC-␣ (Fig. 2A) and PKC-(Fig. 2C) isoforms in the cardiomyopathic hearts compared to control hearts, whereas the protein content of PKC-␤ (Fig. 2B) and PKC-␦ (Fig. 2D) isoforms in cardiomyopathic hearts was not significantly different from the control group. In cardiomyopathic hamsters, the phosphorylated p38
MAPK content in the heart was increased significantly compared to the control group but there was no difference in the unphosphorylated p38 MAPK content (Fig. 3A and B) . As shown in Fig. 3C and D, the levels of phosphorylated Erk1/2 content decreased significantly by 47% and 51% in cardiomyopathic hearts compared to the control animals, respectively, whereas there was no difference in protein content of unphosphorylated Erk1/2. Figure 4A shows a significant decrease of phosphorylated BAD content by 158% in cardiomyopathic hamsters in comparison to the control animals without any difference in the level of unphosphorylated BAD content (Fig. 4A) . The phosphorylated Bcl-2 protein content was also decreased significantly in cardiomyopathic hearts compared to control groups but no difference was evident in the unphosphorylated Bcl-2 protein level (Fig. 4B ).
Protein content for NFB and caspases 3 and 9, cardiomyocyte apoptosis and TNF-␣ production
As shown in Fig. 5A [37] [38] [39] [40] . It should be mentioned that the JN2-k cardiomyopathic hamsters have been shown to experience a slow progression of interstitial fibrosis that parallels the focal necrosis in the heart throughout their life [47] .
Cardiac dysfunction in the J2N-k hamster model of dilated cardiomypathy was associated with a marked increase in the level of TNF-␣ in the myocardium. TNF-␣ has also been reported to be
Fig. 2 PKC protein levels of isoform ␣ (A), isoform ␤ (B), isoform (C) and isoform ␦ (D) in control (CON) and cardiomyopathic (CM) hamsters. *P Ͻ 0.05 versus control; (n ϭ 6).
increased in patients with dilated cardiomyopathy [48] [49] [50] [51] . Because the cardiac contractile failure due to ischaemia-reperfusion injury [9, 32, 52, 53] as well as due to the induction of Ca 2ϩ -paradox [8, 33] [5, 10, 24, 25, 27, 31] . Although high concentrations of TNF-␣ have been reported to depress cardiac contractile force development [5, 10] , the indirect effects of TNF-␣ for inducing cardiac dysfunction in dilated cardiomyopathy cannot be ruled out. Furthermore, cardiac dysfunction in dilated cardiomyopathy in the J2N-k cardiomyopathic hamsters has been reported to be associated with abnormalities in the sarcoplasmic reticulum and extracellular matrix [41, 44, 47] , whereas that in the Bio 53.58 strain of cardiomyopathic hamsters is associated with remodelling of myofibrils and collagen [43, 54] . Cardiac dysfunction in dog-dilated cardiomyopathy induced by rapid pacing has been attributed to the development of oxidative stress [36] caspases 3 and 9 as well as cardiomyocyte apoptosis have been reported in dog-dilated cardiomyopathy due to rapid pacing [36] . In fact, the presence of cardiomyocyte apoptosis has also been observed in different types of failing hearts in patients as well as several experimental models of heart failure [1, [27] [28] [29] [30] [31] [55] . 
is associated with an increased level of TNF-␣, it is likely that this cytokine may be involved in the development of cardiac dysfunction in the hamster-dilated cardiomyopathy. This view is supported by the findings that heart failure in both patients and different experimental animals has been observed to be associated with elevated levels of TNF-␣ in the myocardium
